SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Asplund Kjell) "

Sökning: WFRF:(Asplund Kjell)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Nordanstig, Annika, et al. (författare)
  • Evaluation of the Swedish National Stroke Campaign : A population-based time-series study
  • Ingår i: International Journal of Stroke. - : Wiley-Blackwell. - 1747-4930 .- 1747-4949. ; 14:9, s. 862-870
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Time delay from stroke onset to hospital arrival is an important obstacle to recanalization therapy. To increase knowledge about stroke symptoms and potentially reduce delayed hospital arrival, a 27-month national public information campaign was conducted in Sweden. Aim: To assess the effects of a national stroke campaign in Sweden. Methods: This nationwide study included 97,840 patients with acute stroke, admitted to hospital and registered in the Swedish Stroke Register from 1 October 2010 to 31 December 2014 (one year before the campaign started to one year after the campaign ended). End points were (1) proportion of patients arriving at hospital within 3 h of stroke onset and (2) the proportion < 80 years of age receiving recanalization therapy. Results: During the campaign, both the proportion of patients arriving at hospital within 3 h (p < 0.05) and the proportion receiving recanalization therapy (p < 0.001) increased. These proportions remained stable the year after the campaign, and no significant improvements with respect to the two end points were observed during the year preceding the campaign. In a multivariable logistic regression model comparing the last year of the campaign with the year preceding the campaign, the odds ratio of arriving at hospital within 3 h was 1.05 (95% confidence interval (CI): 1.00–1.09) and that of receiving recanalization was 1.34 (95% CI: 1.24–1.46). Conclusion: The Swedish National Stroke Campaign was associated with a sustained increase in the proportion of patients receiving recanalization therapy and a small but significant improvement in the proportion arriving at hospital within 3 h.
  •  
2.
  • Nordanstig, Annika, 1974, et al. (författare)
  • Impact of the Swedish National Stroke Campaign on stroke awareness
  • 2017
  • Ingår i: Acta Neurologica Scandinavica. - : Wiley-Blackwell. - 0001-6314 .- 1600-0404. ; 136:4, s. 345-351
  • Tidskriftsartikel (refereegranskat)abstract
    • BackgroundTime delay from stroke onset to arrival in hospital is an important obstacle to widespread reperfusion therapy. To increase knowledge about stroke, and potentially decrease this delay, a 27-month national public information campaign was carried out in Sweden. MethodsThe variables used to measure campaign effects were knowledge of the AKUT test [a Swedish equivalent of the FAST (Face-Arm-Speech-Time)] test and intent to call 112 (emergency telephone number) . Telephone interviews were carried out with 1500 randomly selected people in Sweden at eight points in time: before, three times during, immediately after, and nine, 13 and 21months after the campaign. ResultsBefore the campaign, 4% could recall the meaning of some or all keywords in the AKUT test, compared with 23% during and directly after the campaign, and 14% 21months later. Corresponding figures were 15%, 51%, and 50% for those remembering the term AKUT and 65%, 76%, and 73% for intent to call 112 when observing or experiencing stroke symptoms. During the course of the campaign, improvement of stroke knowledge was similar among men and women, but the absolute level of knowledge for both items was higher for women at all time points. ConclusionThe nationwide campaign substantially increased knowledge about the AKUT test and intention to call 112 when experiencing or observing stroke symptoms, but knowledge declined post-intervention. Repeated public information therefore appears essential to sustain knowledge gains.
  •  
3.
  • Wiklund, Per-Gunnar, et al. (författare)
  • Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke : replicated findings in two nested case-control studies based on independent cohorts.
  • 2005
  • Ingår i: Stroke. - 0039-2499 .- 1524-4628. ; 36:8, s. 1661-1665
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND AND PURPOSE: Impaired fibrinolytic function secondary to elevated plasminogen activator inhibitor-1 (PAI-1) levels has been implicated in ischemic stroke. PAI-1 levels are determined by genetic factors and environmental factors, triglyceride levels in particular. The aim of this study was to investigate the common functional 4/5 guanosine (4G/5G) polymorphism in the promoter region of the PAI-1 gene and the risk of stroke. METHODS: A nested case-control study design was applied, using baseline data for 2 independent cohorts obtained at population-based surveys in northern Sweden. In study A, there were 113, and in study B, there were 275 individuals without major concomitant disease at baseline who later experienced a first-ever stroke. Blood samples obtained at baseline were analyzed for potential risk factors, including the 4G/5G polymorphism of the PAI-1 gene. RESULTS: The 4G allele of the PAI-1 polymorphism was associated with an increased risk of future ischemic stroke in both studies (odds ratio [OR] of 4G homozygosity, 1.87; 95% CI, 1.12 to 3.15 in study A; OR of 4G homozygosity, 1.56; 95% CI, 1.12 to 2.16 in study B). Individuals with the combination of hypertriglyceridemia and 4G homozygosity were at the greatest risk of developing stroke. Multiple logistic regression analysis identified 4G homozygosity, systolic blood pressure, and diabetes as independent predictors of ischemic stroke. CONCLUSIONS: Identical findings in 2 independent studies strongly suggest a true and clinically important association between PAI-1 4G/5G genotype and risk of future ischemic stroke. The observed modification of the genotype effect by triglycerides may be interpreted as a gene-environment interaction.
  •  
4.
  • Asplund, Kjell, et al. (författare)
  • Diagnostic procedures, treatments, and outcomes in stroke patients admitted to different types of hospitals
  • 2015
  • Ingår i: Stroke. - : Lippincott Williams & Wilkins. - 0039-2499 .- 1524-4628. ; 46:3, s. 806-812
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and Purpose: In many countries, including Sweden, initiatives have been taken to reduce between-hospital differences in the quality of stroke services. We have explored to what extent hospital type (university, specialized nonuniversity, or community hospital) influences hospital performance. Methods: Riksstroke collects clinical data during hospital stay (national coverage 94%). Follow-up data at 3 months were collected using administrative registers and a questionnaire completed by surviving patients (response rate 88%). Structural data were collected from a questionnaire completed by hospital staff (response rate 100%). Multivariate analyses with adjustment for clustering were used to test differences between types of hospitals. Results: The proportion of patients admitted directly to a stroke unit was highest in community hospitals and lowest in university hospitals. Magnetic resonance, carotid imaging, and thrombectomy were more frequently performed in university hospitals, and the door-to-needle time for thrombolysis was shorter. Secondary prevention with antihypertensive drugs was used less often, and outpatient follow-up was less frequent in university hospitals. Fewer patients in community hospitals were dissatisfied with their rehabilitation. After adjusting for possible confounders, poor outcome (dead or activities of daily living dependency 3 months after stroke) was not significantly different between the 3 types of hospital. Conclusions: In a setting with national stroke guidelines, stroke units in all hospitals, and measurement of hospital performance and benchmarking, outcome (after case-mix adjustment) is similar in university, specialized nonuniversity, and community hospitals. There seems to be fewer barriers to organizing well-functioning stroke services in community hospitals compared with university hospitals.
  •  
5.
  • Asplund, Kjell, et al. (författare)
  • End of life after stroke : a nationwide study of 42,502 deaths occurring within a year after stroke
  • 2018
  • Ingår i: European Stroke Journal. - : Sage Publications. - 2396-9873 .- 2396-9881. ; 3:1, s. 74-81
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: In the scientific literature, there is very limited empirical information on end-of-life issues after stroke in the scientific literature. The present nationwide study describes the circumstances surrounding deaths that occur within a year after a stroke. Patients and methods: Datasets from three nationwide Swedish registers (on stroke, palliative care and cause of death) were linked. Basic information was available for 42,502 unselected cases of death that occurred within a year after a stroke and more detailed information was available for 16,408 deaths. Odds ratios for characteristics of end-of-life care were calculated by logistic regression. Results: In the late phase after stroke (three months to one year), 46% of patients died in a nursing home, whereas 37% of patients died in a hospital after readmission and 10% of patients died at home. Eleven per cent of deaths were reported as being unexpected. A next of kin was present at 49% of deaths. The frequency of unattended deaths (neither next of kin nor staff were present at the time of death) ranged from 5% at home with specialised home care to 25% in hospitals. Discussion: This is, by far, the largest study published on end-of-life issues after stroke. Major differences between countries in healthcare, community services, family structure and culture may limit direct transfer of the present results to other settings. Conclusion: There is considerable discordance between presumed good death' late after stroke (dying at home surrounded by family members) and the actual circumstances at the end of life.
  •  
6.
  • Asplund, Kjell, et al. (författare)
  • Patient Dissatisfaction With Acute Stroke Care.
  • 2009
  • Ingår i: Stroke; a journal of cerebral circulation. - : American Heart Association. - 1524-4628 .- 0039-2499. ; 40, s. 3851-3856
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND AND PURPOSE: Riks-Stroke, the Swedish Stroke Register, was used to explore patient characteristics and stroke services as determinants of patient dissatisfaction with acute in-hospital care. METHODS: All 79 hospitals in Sweden admitting acute stroke patients participate in Riks-Stroke. During 2001 to 2007, 104 876 patients (87% of survivors) responded to a follow-up questionnaire 3 months after acute stroke; this included questions on satisfaction with various aspects of stroke care. RESULTS: The majority (>90%) were satisfied with acute in-hospital stroke care. Dissatisfaction was closely associated with outcome at 3 months. Patient who were dependent regarding activities of daily living, felt depressed, or had poor self-perceived general health were more likely to be dissatisfied. Dissatisfaction with global acute stroke care was linked to dissatisfaction with other aspects of care, including rehabilitation and support by community services. Patients treated in stroke units were less often dissatisfied than patients in general wards, as were patients who had been treated in a small hospital (vs medium or large hospitals) and patient who had participated in discharge planning. In multivariate analyses, the strongest predictor of dissatisfaction with acute care was poor outcome (dependency regarding activities of daily living, depressed mood, poor self-perceived health). CONCLUSIONS: Dissatisfaction with in-hospital acute stroke care is part of a more extensive complex comprising poor functional outcome, depressive mood, poor self-perceived general health, and dissatisfaction not only with acute care but also with health care and social services at large. Several aspects of stroke care organization are associated with a lower risk of dissatisfaction.
  •  
7.
  • Atterman, Adriano, et al. (författare)
  • Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer : a nationwide cohort study
  • 2020
  • Ingår i: Europace. - : Oxford University Press. - 1099-5129 .- 1532-2092. ; 22:1, s. 58-65
  • Tidskriftsartikel (refereegranskat)abstract
    • Aims: To estimate the net cerebrovascular benefit of prophylactic treatment with oral anticoagulants (OACs) in patients with atrial fibrillation (AF) and active cancer.Methods and results: We included all Swedish patients who had been diagnosed with AF in a hospital or in a hospital-associated outpatient unit between 1 July 2005 and 1 October 2017. Patients with active cancer (n = 22 596) and without cancer (n = 440 848) were propensity score matched for the likelihood of receiving OACs at baseline. At baseline, 38.3% of cancer patients with AF and high stroke risk according to CHA2DS2-VASc score received OACs. There was a net benefit of OACs, assessed by the composite outcome of ischaemic stroke, extracranial arterial thromboembolism, all major bleedings, and death, both among patients with active cancer [hazard ratio (HR): 0.81, confidence interval (CI): 0.78-0.85] and among patients without cancer (HR: 0.81, CI: 0.80-0.82). When limiting follow-up to 1 year to minimize the effects of possible treatment cross-over and additionally accounting for death as a competing risk in cancer patients, a net cerebrovascular benefit regarding ischaemic stroke or intracranial bleeding was observed for OACs [subhazard ratio (sHR): 0.67, CI: 0.55-0.83]. A net cerebrovascular benefit was also seen for non-vitamin K antagonist OACs over warfarin after competing risk analyses in cancer patients (sHR: 0.65, CI: 0.48-0.88).Conclusion: Patients with AF and active cancer benefit from OAC treatment.
  •  
8.
  •  
9.
  •  
10.
  • Eriksson, Marie, et al. (författare)
  • Discarding Heparins as Treatment for Progressive Stroke in Sweden 2001 to 2008
  • 2010
  • Ingår i: Stroke: a journal of cerebral circulation. - : American Heart Association. - 1524-4628 .- 0039-2499. ; 41:11, s. 2552-2558
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and Purpose-High-dose heparin has been used extensively to treat patients with progressive ischemic stroke, but the scientific support is poor and the current stroke guidelines advise against its use. We studied how heparin treatment for progressive stroke has been discarded in Sweden. Methods-All 78 hospitals in Sweden that admit acute stroke patients participate in Riks-Stroke, the Swedish Stroke Register. During 2001 to 2008, information on the use of high-dose heparin was available for 155 344 patients with acute ischemic stroke. The determinants as to region, patient characteristics, and stroke service settings were analyzed. Results-Use of heparin for progressive stroke declined from 7.5% (2001) to 1.6% (2008) of all patients with ischemic stroke. The marked regional differences present in 2001 were reduced over time. The use of heparin declined at a similar rate in all types of hospital settings, in stroke units vs nonstroke units, and in neurological vs medical wards. Independent predictors of use of heparin included younger age, first-ever stroke, independence in activities of daily living before stroke, atrial fibrillation, no aspirin treatment, and lowered consciousness on admission. Conclusions-There is no immediate, stepwise effect of new scientific information and national guidelines on clinical practice. Rather, the phasing out of heparin has followed a linear course over several years, with less variation between hospitals. We speculate that open comparisons between hospitals in a national stroke register may have helped to reduce the variations in clinical practice. (Stroke. 2010;41:2552-2558.)
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (138)
rapport (8)
doktorsavhandling (7)
konferensbidrag (5)
forskningsöversikt (5)
annan publikation (4)
visa fler...
samlingsverk (redaktörskap) (1)
bok (1)
bokkapitel (1)
visa färre...
Typ av innehåll
refereegranskat (118)
övrigt vetenskapligt (47)
populärvet., debatt m.m. (5)
Författare/redaktör
Asplund, Kjell (147)
Norrving, Bo (38)
Eriksson, Marie (34)
Stegmayr, Birgitta (33)
Glader, Eva-Lotta (26)
Terent, Andreas (25)
visa fler...
Asplund, K (25)
Norrving, B (14)
Appelros, Peter (12)
Eriksson, Kjell (9)
Norberg, Astrid (9)
Wiklund, Per-Gunnar (9)
Axelsson, Karin (9)
Stegmayr, B. (9)
Terent, A (9)
Jonsson, Fredrik (9)
Holmberg, Dan (8)
Asberg, Kerstin Hult ... (8)
Åsberg, Kerstin Hult ... (8)
Jonsson, Håkan (7)
Lind, Lars (7)
Asplund, M. (7)
Wester, Per-Olov (7)
Castrén, Maaret (7)
Ehrenberg, Anna (7)
Farrokhnia, Nasim (7)
Göransson, Katarina (7)
Oredsson, Sven (7)
Lindahl, Bernt (6)
Wester, P (6)
Hulter Åsberg, Kerst ... (6)
Norlund, Anders (5)
Lindblom, Jonas (5)
Aoki, W (5)
Frebel, A (5)
Asberg, Signild (5)
Rognes, Jon (5)
Berne, Christian (4)
Eriksson, M (4)
Gustafsson, Bengt (4)
Berglund, Göran (4)
Lindgren, Petter (4)
Eliasson, Mats (4)
Nilsson, Anna-Karin (4)
Wahlgren, N (4)
Barklem, Paul (4)
Andersson Escher, St ... (4)
Carlberg, Bo (4)
Åsberg, Signild (4)
Wester, Per (4)
visa färre...
Lärosäte
Umeå universitet (123)
Lunds universitet (33)
Uppsala universitet (28)
Luleå tekniska universitet (9)
Göteborgs universitet (6)
Karolinska Institutet (6)
visa fler...
Högskolan Dalarna (4)
Stockholms universitet (2)
Linköpings universitet (2)
Mälardalens högskola (1)
Linnéuniversitetet (1)
visa färre...
Språk
Engelska (136)
Svenska (32)
Odefinierat språk (1)
Spanska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (100)
Naturvetenskap (7)
Samhällsvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy